BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 29181566)

  • 1. Could
    Piccardo A; Treglia G
    Eur J Nucl Med Mol Imaging; 2018 Feb; 45(2):247-249. PubMed ID: 29181566
    [No Abstract]   [Full Text] [Related]  

  • 2. (68)Ga-somatostatin analogues PET and (18)F-DOPA PET in medullary thyroid carcinoma.
    Ambrosini V; Marzola MC; Rubello D; Fanti S
    Eur J Nucl Med Mol Imaging; 2010 Jan; 37(1):46-8. PubMed ID: 19690853
    [No Abstract]   [Full Text] [Related]  

  • 3. Primary Neuroendocrine Tumor in a Horseshoe Kidney With Positive 111In-Pentetreotide Somatostatin Receptor Scintigraphy and Negative 18F-DOPA PET/CT.
    Gauthé M; Lièvre A; Alberini JL
    Clin Nucl Med; 2015 Nov; 40(11):e516-7. PubMed ID: 26204216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Staging of carcinoid tumours with 18F-DOPA PET: a prospective, diagnostic accuracy study.
    Koopmans KP; de Vries EG; Kema IP; Elsinga PH; Neels OC; Sluiter WJ; van der Horst-Schrivers AN; Jager PL
    Lancet Oncol; 2006 Sep; 7(9):728-34. PubMed ID: 16945767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear Medicine in Patients with NET: Radiolabeled Somatostatin Analogues and their Brothers.
    Cuccurullo V; Prisco MR; Di Stasio GD; Mansi L
    Curr Radiopharm; 2017; 10(2):74-84. PubMed ID: 28332450
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    El-Maouche D; Sadowski SM; Papadakis GZ; Guthrie L; Cottle-Delisle C; Merkel R; Millo C; Chen CC; Kebebew E; Collins MT
    J Clin Endocrinol Metab; 2016 Oct; 101(10):3575-3581. PubMed ID: 27533306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 6-[F-18]Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with (123)I-metaiodobenzylguanidine scintigraphy, computer tomography, and magnetic resonance imaging in localizing tumors causing catecholamine excess.
    Fiebrich HB; Brouwers AH; Kerstens MN; Pijl ME; Kema IP; de Jong JR; Jager PL; Elsinga PH; Dierckx RA; van der Wal JE; Sluiter WJ; de Vries EG; Links TP
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3922-30. PubMed ID: 19622618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Feasibility of domestic (18)F-DOPA PET/CT scanning in the differential diagnosis of pancreatic lesions in children with hyperinsulinemic hypoglycemia].
    Zhang MY; Ge JJ; Pei Z; Dong KR; Chen L; Wang X; Zhang ZW; Li XJ; Xi L; Cheng RQ; Lu GP; Guan YH; Luo FH
    Zhonghua Er Ke Za Zhi; 2017 Oct; 55(10):785-789. PubMed ID: 29050119
    [No Abstract]   [Full Text] [Related]  

  • 9. Prospective comparison of (68)Ga-DOTATATE and (18)F-FDOPA PET/CT in patients with various pheochromocytomas and paragangliomas with emphasis on sporadic cases.
    Archier A; Varoquaux A; Garrigue P; Montava M; Guerin C; Gabriel S; Beschmout E; Morange I; Fakhry N; Castinetti F; Sebag F; Barlier A; Loundou A; Guillet B; Pacak K; Taïeb D
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1248-57. PubMed ID: 26637204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of 18F-dopa PET/CT imaging in the management of patients with 111In-pentetreotide negative GEP tumours.
    Ambrosini V; Tomassetti P; Rubello D; Campana D; Nanni C; Castellucci P; Farsad M; Montini G; Al-Nahhas A; Franchi R; Fanti S
    Nucl Med Commun; 2007 Jun; 28(6):473-7. PubMed ID: 17460538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of different positron emission tomography tracers in patients with recurrent medullary thyroid carcinoma: our experience and a review of the literature.
    Treglia G; Castaldi P; Villani MF; Perotti G; Filice A; Ambrosini V; Cremonini N; Versari A; Fanti S; Giordano A; Rufini V
    Recent Results Cancer Res; 2013; 194():385-93. PubMed ID: 22918771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved staging of patients with carcinoid and islet cell tumors with 18F-dihydroxy-phenyl-alanine and 11C-5-hydroxy-tryptophan positron emission tomography.
    Koopmans KP; Neels OC; Kema IP; Elsinga PH; Sluiter WJ; Vanghillewe K; Brouwers AH; Jager PL; de Vries EG
    J Clin Oncol; 2008 Mar; 26(9):1489-95. PubMed ID: 18349401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of (68)Ga-DOTA-Tyr(3)-octreotide and (18)F-fluoro-L-dihydroxyphenylalanine positron emission tomography in neuroendocrine tumor patients.
    Putzer D; Gabriel M; Kendler D; Henninger B; Knoflach M; Kroiss A; Vonguggenberg E; Warwitz B; Virgolini IJ
    Q J Nucl Med Mol Imaging; 2010 Feb; 54(1):68-75. PubMed ID: 20168288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifocal extra-adrenal paraganglioma evaluated with different PET tracers: comparison between 18F-FDG, 18F-DOPA and 68Ga DOTANOC PET/CT.
    Treglia G; Cardillo G; Stefanelli A; Di Franco D; Enang GN; Giordano A; Rufini V
    Clin Nucl Med; 2013 Dec; 38(12):e458-62. PubMed ID: 23486329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-DOPA PET/CT but not 68Ga-DOTA-TOC PET/CT revealed the underlying cause of ectopic Cushing syndrome.
    Schalin-Jäntti C; Ahonen A; Seppänen M
    Clin Nucl Med; 2012 Sep; 37(9):904-5. PubMed ID: 22889786
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Segard T; Morandeau LM; Geelhoed EA; Francis RJ
    J Med Imaging Radiat Oncol; 2018 Feb; 62(1):57-63. PubMed ID: 28714296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The predictive value of preoperative fluorine-18-L-3,4-dihydroxyphenylalanine positron emission tomography-computed tomography scans in children with congenital hyperinsulinism of infancy.
    Zani A; Nah SA; Ron O; Totonelli G; Ismail D; Smith VV; Ashworth M; Blankenstein O; Mohnike W; De Coppi P; Eaton S; Hussain K; Pierro A
    J Pediatr Surg; 2011 Jan; 46(1):204-8. PubMed ID: 21238668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical value of 18-fluorine-fluorodihydroxyphenylalanine positron emission tomography/computed tomography in the follow-up of medullary thyroid carcinoma.
    Luster M; Karges W; Zeich K; Pauls S; Verburg FA; Dralle H; Glatting G; Buck AK; Solbach C; Neumaier B; Reske SN; Mottaghy FM
    Thyroid; 2010 May; 20(5):527-33. PubMed ID: 20450432
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Calabrò D; Allegri V; Fanti S; Ambrosini V
    Eur J Nucl Med Mol Imaging; 2019 Jun; 46(6):1393. PubMed ID: 30874857
    [No Abstract]   [Full Text] [Related]  

  • 20. Somatostatin receptor imaging-guided pasireotide therapy in medullary thyroid cancer with ectopic adrenocorticotropin production.
    Verburg FA; Anlauf M; Mottaghy FM; Karges W
    Clin Nucl Med; 2015 Jan; 40(1):e83-4. PubMed ID: 24999678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.